Pharmaceutical industry
GlaxoSmithKline's ViiV Healthcare, a global specialist HIV company, has reached a settlement with Gilead Sciences in a patent infringement case over the antiretroviral medication dolutegravir. The dispute centered on Gilead's Biktarvy, a triple combination HIV medicine containing bictegravir, which was allegedly infringing on ViiV Healthcare'
COVID-19
Children's Health Defense (CHD) is strongly opposing the U.S. Food and Drug Administration's (FDA) push for emergency use authorization (EUA) of a COVID vaccine for children between six months and five years old, citing the lack of risk to this age group and the availability
Pharmaceutical industry
The vitamin D market is expected to witness significant growth in the coming years, driven by increasing awareness about the importance of vitamin D, growing demand for health supplements, and strong presence of key vendors in the market. According to a recent market study by Technavio, the vitamin D market
Vaccines
The United States, under increasing pressure to share its COVID-19 vaccine supply, has promised to donate 500 million more vaccine doses to developing countries. This announcement was made by President Joe Biden during a virtual summit aimed at boosting global vaccination rates against the coronavirus. The additional vaccines will bring
Pharmaceutical industry
Researchers from Japan have conducted a prospective, observational study to evaluate the safety of the SARS-CoV-2 vaccine in patients with advanced lung cancer receiving anticancer therapy. The study, published in Thoracic Cancer, aimed to assess the occurrence of early adverse events within 7 days of vaccine injection in patients undergoing
Vaccines
The COVID-19 pandemic continues to take a toll on Canada, with a vaccine hesitancy expert expressing concern over the slow vaccination rate of children between the ages of five and 11, and paramedics calling for improved mental health services due to staff shortages and unprecedented call volumes. Preliminary data from
Pharmaceutical industry
The past week has seen significant developments in the regulatory affairs space, with updates on FDA approvals, rejections, and guidance, as well as the ongoing COVID-19 pandemic. The US FDA has approved the use of antiviral drug remdesivir as an outpatient therapy for people with COVID-19, while also rejecting Merck&
Pharmaceutical industry
Pharma companies continued to evolve their advertising strategies in 2021, as both COVID-19 vaccines and autoimmune treatments dominated the landscape. While AbbVie's Humira maintained a high level of spending, it took a hit from Pfizer's COVID-19 vaccine and was ultimately surpassed by Sanofi and Regeneron'
Vaccines
Despite the disruptions caused by the COVID-19 pandemic, the biopharma industry has managed to keep projects moving by leveraging collaborations. With vaccines like the Pfizer-BioNTech mRNA vaccine serving as a testament to the industry's ability to work together, experts predict that collaborations will continue to play a crucial
Pharmaceutical industry
The drug discovery industry has been significantly impacted by the COVID-19 pandemic, with temporary breaks in clinical trials and a shift towards remote and virtual study methods. However, the pandemic has also led to the emergence of new working ways, and technological advancements are simplifying the complex procedures in drug
Vaccines
Loblaw pharmacies are taking steps to make COVID-19 vaccinations more accessible for children aged 5-11 in Ontario as in-person learning resumes. Select pharmacies at Real Canadian Superstore and Fortinos locations will host vaccine clinics, offering first and second dose pediatric Pfizer vaccines by appointment only. This initiative aims to protect
Vaccines
South Korea's Ministry of Food and Drug Safety authorized the use of the Novavax COVID-19 vaccine, making it the fifth vaccine to receive approval in the country. The vaccine, Nuvaxovid, is a protein-based vaccine developed by U.S.-based biotechnology company Novavax Inc. It will be distributed by
